In Vivo - Strategic Analysis For Medtech And Pharma Leaders since 1981

Podcasts


Innovation


The Practice-Changing Drugs That Will Graduate In 2025

The Practice-Changing Drugs That Will Graduate In 2025

 
• By 

A wealth of new therapies are set to successfully graduate from the pipeline in 2025. Within this cohort are a mixture of therapeutic areas, drug classes, first-time approvals, label expansions, and treatments that will meaningfully change how diseases are treated.

Korea Lays Out Roadmap For Use Of AI Across Drug Development

 
• By 

The five-year roadmap aims to expand support for AI research and development in essential health care and new drug development, as well as advance medical data usage systems and enable its safe use.

Market Access